Data were collected from a participants EHR and transformed into the Observational Medical Outcomes Partnership (OMOP) Common Data Model v5.4
Health Canadas Drug Product Database can be searched for Canadian product monographs and regulatory details
Endocrinology 152:31033112 Wettergren A, Wojdemann M, Holst JJ (1998) Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow
If the goal is weight loss, says Dan Azagury, a physician at Stanford University who specializes in treating obesity, the safest, most effective way to accomplish that is to seek out the help of a doctor who specializes in treating obesity
And I really, really trust him on everything
Review Medication Interactions Some medications you take may have an impact on weight loss